tradingkey.logo

Cardio Diagnostics Holdings Inc

CDIOW
0.018USD
+0.001+8.28%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
0.00Valor de mercado
--P/L TTM

Cardio Diagnostics Holdings Inc

0.018
+0.001+8.28%

Mais detalhes de Cardio Diagnostics Holdings Inc Empresa

Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.

Informações de Cardio Diagnostics Holdings Inc

Código da empresaCDIOW
Nome da EmpresaCardio Diagnostics Holdings Inc
Data de listagemNov 23, 2021
CEODr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Número de funcionários- -
Tipo de títulosCompany Warrant
Fim do ano fiscal- -
Endereço311 W. Superior Street
CidadeCHICAGO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal60645
Telefone18552269991
Site
Código da empresaCDIOW
Data de listagemNov 23, 2021
CEODr. Meeshanthini V. (Meesha) Dogan, Ph.D.

Executivos da empresa Cardio Diagnostics Holdings Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
--
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Peter K. Fung
Mr. Peter K. Fung
Independent Director
Independent Director
--
--
Mr. Paul F. Burton, J.D.
Mr. Paul F. Burton, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy J. Betts
Ms. Wendy J. Betts
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
--
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--

Detalhamento da receita

Os dados relevantes ainda não foram divulgados pela empresa.
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: sex, 2 de jan
Atualizado em: sex, 2 de jan
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Outro
100.00%
Investidores
Investidores
Proporção
Outro
100.00%
Tipos de investidores
Investidores
Proporção
Outro
100.00%

Participação acionária institucional

Atualizado em: qua, 21 de jan
Atualizado em: qua, 21 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q4
12
726.58K
0.00%
--
2025Q4
21
730.35K
0.00%
-622.32K
2025Q3
22
726.58K
0.00%
+121.27K
2025Q2
22
605.31K
0.00%
+24.34K
2025Q1
21
580.97K
0.00%
-805.01K
2024Q4
27
580.02K
0.00%
-388.74K
2024Q3
29
968.76K
0.00%
+35.91K
2024Q2
31
932.85K
0.00%
-265.62K
2024Q1
31
1.20M
0.00%
-1.20M
2023Q4
31
1.25M
0.00%
-47.09K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Virtu Americas LLC
--
0%
-14.51K
-100.00%
Jun 30, 2024
Walleye Trading, LLC
--
0%
-132.26K
-100.00%
Dec 31, 2024
Susquehanna International Group, LLP
53.25K
0%
+39.54K
+288.49%
Sep 30, 2025
Citadel Advisors LLC
--
0%
-11.63K
-100.00%
Dec 31, 2024
UBS Financial Services, Inc.
151.00
0%
-774.00
-83.68%
Sep 30, 2025
Clear Street Group Inc
82.64K
0%
+82.64K
--
Sep 30, 2025
Two Sigma Investments, LP
10.53K
0%
-35.00
-0.33%
Sep 30, 2025
TD Securities, Inc.
100.00
0%
-100.00
-50.00%
Sep 30, 2025
EHP Funds Inc.
--
0%
-228.95K
-100.00%
Jun 30, 2024
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI